Warner-Lambert v Actavis ‘disappointing’ for innovators: lawyers
15-11-2018
UK Supreme Court issues Warner-Lambert v Actavis ruling
14-11-2018
UK Supreme Court grants BIA intervention request in plausibility case
18-01-2018
tupungato / iStockphoto.com
Infringement and plausibility were the biggest issues on the battleground in the UK Supreme Court’s hearing in a case dealing with second medical use patents, as Claire Phipps-Jones, Katie Cambrook and Rachel Mumby of Bristows report.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Warner Lambert, UK Supreme Court, UK BioIndusry Association, Actavis, Mylan, patent, patent invalidity, plausibility, Bristows
